Filter news by date News Tags - Any -News storyPress release Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Year Year2024202320222021202020192018201720162015201420132012201120102009200820072006 Apply 7 . 6 . 2020 Press release On International Kissing Day, Galderma Shares First-of-its-Kind Phase IV Kissability Study Results Showing Both Subject and Partner Satisfaction with Restylane® Kysse 6 . 10 . 2020 Press release Galderma global research reveals struggles of people with rosacea and psoriasis of the face experiencing a lack of control and impact on mental wellbeing 5 . 12 . 2020 Press release Galderma Announces Top-Line Results of Clinical Study Showing Patients Treated with Dysport® (abobotulinumtoxinA) Achieved High Levels of Satisfaction and Natural-Looking Results with Two Treatments Per Year 5 . 6 . 2020 Press release Galderma Receives FDA Approval For Restylane® Kysse, A New Hyaluronic Acid (HA) Filler Specifically Designed And Indicated To Add Fullness To The Lips And Help Smooth The Wrinkles Above The Mouth 5 . 5 . 2020 Press release Galderma closes the sale of Bübchen to Dallmann’s Pharma 5 . 1 . 2020 Press release CETAPHIL by Galderma unites forces to focus on hand health and safety with their "In Good Hands" initiative to fight COVID-19 4 . 22 . 2020 Press release Galderma receives approval for Restylane® Vital™, Restylane® Lyft™, and Restylane® Lidocaine in China 4 . 15 . 2020 Press release Galderma demonstrates continued commitment to aesthetic education by offering new series of digital webinars* 3 . 4 . 2020 Press release Galderma Announces an Acceleration of its Growth and Expansion Plans to Support Aesthetic Providers 3 . 3 . 2020 Press release Differin® Launches Clear90™ App, to Support People with Acne on Their Clear Skin Journey as Part of Third-Annual Retinoid Education Week 2 . 20 . 2020 Press release Galderma Announces New England Journal of Medicine Publication from Phase 2 Study of Investigational Therapy Nemolizumab in Patients with Moderate to Severe Prurigo Nodularis 12 . 20 . 2019 Press release Galderma receives a positive outcome through the European Decentralised Procedure for AKLIEF® (trifarotene 50 mcg/g cream), the first new retinoid molecule for acne in the European Union in 25 years Pagination Previous page Previous Page Next page Next Page